• FirefoxInstall the new Firefox »
  •  Dow Up 0.66% Nasdaq Up 0.67%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    103.72 Up 0.19(0.18%) 3:07PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:103.53
    Open:104.30
    Bid:103.54 x 200
    Ask:103.55 x 400
    1y Target Est:119.04
    Beta:0.83
    Earnings Date:Apr 20 - Apr 24 (Est.)
    Day's Range:102.80 - 104.30
    52wk Range:63.50 - 116.83
    Volume:4,714,483
    Avg Vol (3m):16,623,400
    Market Cap:154.48B
    P/E (ttm):14.11
    EPS (ttm):7.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GILD

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 0.18%154.48B
    GSKUp 0.76%114.93B
    PFEUp 0.93%212.30B
    RHHBYDown 0.44%N/A

    Key Statistics

    Forward P/E (1 yr):9.99
    P/S (ttm):6.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :9.53
    Quarterly EPS Est (Mar-15) :2.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback